Soleno Therapeutics, Inc. (SLNO) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 9 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for SLNO is $95.25, representing a +81.0% upside from the current price of $52.62. Price targets range from a low of $60.00 to a high of $114.00.
